Abstract
Introduction
In patients with out-of-hospital cardiac arrest (OHCA) complicating an ST-segment elevation myocardial infarction (STEMI), the survival depends largely on the restoration of coronary flow in the infarct related artery. The aim of this study was to determine clinical and angiographic predictors of in-hospital mortality in patients with OHCA and STEMI, successfully resuscitated and undergoing primary percutaneous intervention (PCI).
Methods
From January 2013 to July 2015, 78 patients with STEMI presenting OHCA, successfully resuscitated, transferred immediately to the catheterization unit and treated with primary PCI, were analyzed. Clinical, laboratory and angiographic data were compared in 28 non-survivors and 50 survivors.
Results
The clinical baseline characteristics of the study population showed no significant differences between the survivors and non-survivors in respect to age (p=0.06), gender (p=0.8), the presence of hypertension (p=0.4), dyslipidemia (p=0.09) obesity (p=1), smoking status (p=0.2), presence of diabetes (p=0.2), a clinical history of acute myocardial infarction (p=0.7) or stroke (p=0.17). Compared to survivors, the non-survivor group exhibited a significantly higher incidence of cardiogenic shock (50% vs 24%, p=0.02), renal failure (64.3% vs 30.0%, p=0.004) and anaemia (35.7% vs 12.0%, p=0.02). Three-vessel disease was significantly higher in the non-survivor group (42.8% vs. 20.0%, p=0.03), while there was a significantly higher percentage of TIMI 3 flow postPCI in the infarct-related artery in the survivor group (80.% vs. 57.1%, p=0.03). The time from the onset of symptoms to revascularization was significantly higher in patients who died compared to those who survived (387.5 +/- 211.3 minutes vs 300.8 +/- 166.1 minutes, p=0.04), as was the time from the onset of cardiac arrest to revascularization (103.0 +/- 56.34 minutes vs 67.0 +/- 44.4 minutes, p=0.002). Multivariate analysis identified the presence of cardiogenic shock (odds ratio [OR]: 3.17, p=0.02), multivessel disease (OR: 3.0, p=0.03), renal failure (OR: 4.2, p=0.004), anaemia (OR: 4.07, p=0.02), need for mechanical ventilation >48 hours (OR: 8.07, p=0.0002) and a duration of stay in the ICU longer than 5 days (OR: 9.96, p=0.0002) as the most significant independent predictors for mortality in patients with OHCA and STEMI.
Conclusion
In patients surviving an OHCA in the early phase of a myocardial infarction, the presence of cardiogenic shock, renal failure, anaemia or multivessel disease, as well as a longer time from the onset of symptoms or of cardiac arrest to revascularization, are independent predictors of mortality. However, the most powerful predictor of death is the duration of stay in the ICU and the requirement of mechanical ventilation for more than forty-eight hours.
Keywords: cardiac arrest, acute myocardial infarction, mechanical ventilation, cardiogenic shock
Introduction
Coronary artery disease continues to represent the leading cause of death worldwide and acute myocardial infarction remains one of its most severe forms, being associated with high mortality rates and other complications. In patients with ST-segment elevation myocardial infarction (STEMI), survival is directly correlated with the timely initiation of reperfusion therapy. Proper network organization is crucial in getting the patient to the catheterization unit expeditious. Large data registries indicate a decrease in mortality from 25% to 5%, following efficient initiation of reperfusion therapy in STEMI cases [1]. Landmark trials such as GUSTO (The Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries) [2] or PRAGUE (PRimary Angioplasty in patients transferred from General community hospitals to specialized PTCA Units with or without Emergency thrombolysis) [3] demonstrate that STEMI associated mortality is directly correlated with the time from the onset of symptoms to the initiation of reperfusion therapy, and that a significant improvement in survival can be achieved if the patient arrives in the catheterization unit within twelve hours from the onset of symptoms. However, a significant number of patients present cardiac arrest as the first manifestation of the acute event [4]. Many patients may not be admitted to a hospital immediately after the onset of symptoms, and suffer a cardiac arrest before reaching the hospital. In many cases the cardiac arrest complicating the acute coronary event could have been successfully resuscitated if specialized care is delivered in time. Survival, after the acute event, depends largely on the restoration of the coronary flow in the infarct-related artery [3], following successful resuscitation. Despite progresses in the last years in the logistics related to delivering health care to this complex cases, (including better organization of ambulance services, availability of external defibrillators in highly populated areas or development of STEMI networks), out-of-hospital cardiac arrest (OHCA) continues to be associated with high mortality rates in STEMI patients, especially in severe cases complicated by cardiogenic shock (CS) [4,5,6,7].
The aim of this study was to determine clinical and angiographic predictors of in-hospital mortality in successfully resuscitated patients who had had a pre-hospital cardiac arrest as a complication of STEMI, and who underwent primary percutaneous intervention (PCI).
Methods
From January 2013 to July 2015, seventy-eight successfully resuscitated patients with STEMI presenting OHCA, transferred immediately to the catheterization unit and treated with primary PCI, were included in the study. All patients underwent immediate coronary angiography and revascularization of the infarct related artery. Clinical, laboratory and angiographic data (including age, weight, gender, history, risk factors, smoking status, cholesterol values, creatinine values, blood sugar, NYHA class, blood pressure, location of culprit lesion and the presence of multivessel disease) were collected and compared in twenty-eight non-survivors (Group 1) and fifty survivors (Group 2). The following critical time intervals were determined and analyzed in survivors and non-survivors:
The time from the onset of symptoms to revascularization (calculated as the time from the onset of symptoms to balloon inflation and stent deployment), representing the ischemic time;
The time from the onset of the cardiac arrest to revascularization.
The duration of stay in the intensive care unit or coronary care unit.
The length of mechanical ventilation.
The study was approved by the ethics committee of both the University of Medicine and Pharmacy of Tirgu Mures, Romania and of the County Clinical Emergency Hospital Tirgu Mures, Romania, and all the investigations were in accordance with the Declaration of Helsinki.
Statistical analysis
The Fisher’s exact test (or the Student’s t-test for age) was used to compare the baseline characteristics of patients in Group1 and Group 2. Continuous values were expressed as the mean and standard deviation, and statistical significance was determined using the Mann-Whitney test. Logistic regression analysis was used to identify independent predictors of death in the study population. Statistical significance was considered for p values < 0.05, and all p values were 2-sided.
All the statistical analyzes were performed using the InStat Graph Pad software.
Results
Baseline and clinical characteristics
The population mean age was 64.8 +/- 11.2 in Group 1 and 68.8 +/- 7.5 in Group 2. The clinical baseline characteristics of the study population showed no significant differences between Groups 1 and 2, with respect to age (p=0.06), gender (p=0.8), the presence of hypertension (p=0.4), dyslipidemia (p=0.09) obesity (p=1), smoking status (p=0.2), presence of diabetes (p=0.2), and clinical history of acute myocardial infarction (p=0.7) or stroke (p=0.17) (table 1).
Table 1.
Baseline characteristics of study population
Group 1 | Group 2 | P value | |
---|---|---|---|
OHCA non-survivors | OHCA survivors | ||
n=28 (35.9%) | n=50 (64.1%) | ||
Age, years | 64.8 +/- 11.2 | 68.8 +/- 7.5 | 0.06 |
Gender, male | 13 (46.4%) | 21 (42.0%) | 0.8 |
Hypertension | 13 (46.4%) | 18 (36.0%) | 0.4 |
Hyperlipidemia | 16 (63.3%) | 18 (36.0%) | 0.09 |
Obesity (BMS>25 km/m2) | 7 (25.0%) | 12 (24.0%) | 1 |
Smoker ∗ | 16 (57.1%) | 21 (42.0%) | 0.2 |
Diabetes | 10 (35.7%) | 11 (22.0%) | 0.2 |
History of AMI | 6 (21.4%) | 9 (18.0%) | 0.7 |
History of stroke | 4 (14.3%) | 5 (10.0%) | 0.7 |
OHCA = out of hospital cardiac arrest
past or present
Mortality in patients with OHCA was positively associated with a worse clinical status at presentation. Compared to Group 2, Group 1 had a significantly higher incidence of cardiogenic shock as a complication of myocardial infarction (50% vs 24%, p=0.02), renal failure (64.3% vs 30.0%, p=0.004) and anaemia (35.7% vs 12.0%, p=0.02) (table 2).
Table 2.
Clinical and angiographic characteristics of the study population
Group 1 | Group 2 | ||
---|---|---|---|
OHCA non-survivors | OHCA survivors | P value | |
n=28 (35.9%) | n=50 (64.1%) | ||
Clinical status at presentation | |||
Cardiogenic shock | 14 (50.0%) | 12 (24.0%) | 0.02 |
Anemia | 10 (35.7%) | 6 (12.0%) | 0.02 |
Renal failure | 18 (64.3%) | 15 (30.0%) | 0.004 |
Angiographic characteristics | |||
Three-vessel disease | 12 (42.8%) | 10 (20.0%) | 0.03 |
TIMI 3 flow in the infarct related artery following PCI | 16 (57.1%) | 40 (80.0%) | 0.03 |
Condition severity | |||
Need for mechanical ventilation for >48 hours | 15 (53.5%) | 6 (12.0%) | 0.0002 |
Stay in the ICU for >5 days | 13 (46.4%) | 4 (8.0%) | 0.0002 |
OHCA = out of hospital cardiac arrest ICU – intensive care unit
Angiographic analysis
Angiographic analysis indicated the presence of a three-vessel disease to a significantly higher extent in Group 1 (42.8% vs. 20.0%, p=0.03), while the complete restoration of coronary flow, expressed by a TIMI 3 flow post-PCI in the infarct-related artery, was significantly higher in Group 2 (80.% vs 57.1%, p=0.03).
Angiographic analysis of the location of the culprit lesion, indicated that in Group 1, the left anterior descending artery (LAD) or the left main (LM) were the two most infarct-related arteries (61% vs 36%, p=0.05 for LAD, and 21% vs 4%, p=0.02 for LM, respectively), while in the Group 2 the infarct-related artery was more frequent the circumflex artery (Cx) or the right coronary artery (RCA) (11% vs. 30%, p=0.09 for Cx and 7% vs. 30%, p=0.02 for RCA, respectively) (Figure 1).
Fig. 1.
Location of the culprit lesion (infarct related artery)
Condition severity
Condition severity and the degree of deterioration of haemodynamic status were significantly associated with a higher mortality in patients with OHCA. Both the need for mechanical ventilation for more than 48 hours and the stay in the ICU for more than five days were significantly higher in the Group 1 compared to Group 2 (Table 2).
The duration of stay in the ICU was significantly higher in Group 1 compared to Group 2 (5.9 +/- 6.0 days vs. 1.5 +/- 1.4 days, p<0.0001).
Group 1 patients were transferred to the coronary care unit (CCU), where the average stay was 2.4 +/- 0.8 days, after which they were transferred to the cardiology ward and then discharged (Figure 2).
Fig. 2.
Duration of stay in intensive care facilities in patients with OHCA
Only a few patients from the Group 1 were transferred to the CCU, as most of them died in the ICU.
Critical time intervals in patients with OHCA
The time from the onset of symptoms to revascularization was significantly higher in patients who died (group 1) as compared to those who survived (group 2) (387.5 +/- 211.3 minutes vs 300.8 +/- 166.1 minutes, p=0.04), as was the time from the onset of cardiac arrest to revascularization (103.0 +/- 56.34 minutes vs 67.0 +/- 44.4 minutes, p=0.002). (Table 3, Figure 3).
Table 3.
Critical time intervals and duration of stay in intensive care facilities in patients with OHCA
Group 1 | Group 2 | ||
---|---|---|---|
OHCA non-survivors | OHCA survivors | p value | |
n=28 (35.9%) | n=50 (64.1%) | ||
Time from symptoms onset to balloon (minutes) | 0.04 | ||
Mean +/- SD | 387.5 +/- 211.3 | 300.8 +/- 166.1 | |
95% confidence interval | 305.6 –469.4 | 253.5−348.0 | |
Time from OHCA to balloon (minutes) | 0.002 | ||
Mean +/- SD | 103.0 +/- 56.34 | 67.0 +/- 44.4 | |
95% confidence interval | 81.2 –124.9 | 54.4−79.6 | |
Duration of stay in the ICU (days) | <0.0001 | ||
Mean +/- SD | 5.9 +/- 6.0 | 1.5 +/- 1.4 | |
95% confidence interval | 3.6 –8.25 | 1.0 − 1.9 | |
Duration of stay in the CCU (days) | <0.0001 | ||
Mean +/- SD | 0.1 +/- 0.4 | 2.4 +/- 0.8 | |
95% confidence interval | −0.03 – 0.3 | 2.1 – 2.6 |
OHCA = out of hospital cardiac arrest; ICU = intensive care unit; CCU = coronary care unit
Fig. 3.
Critical time intervals in patients with OHCA
Predictors for mortality in patients with OHCA and STEMI
The most significant independent predictors of mortality in patients with OHCA and STEMI, were the presence of cardiogenic shock (odds ratio [OR]: 3.17, p=0.02), multi-vessel disease (OR: 3.0, p=0.03), renal failure (OR: 4.2, p=0.004), anaemia (OR: 4.07, p=0.02), need for mechanical ventilation >48 hours (OR: 8.07, p=0.0002) and a duration of stay in the ICU longer than 5 days (OR: 9.96, p=0.0002) (Table 4).
Table 4.
Multivariate predictors of death in patients with out of hospital cardiac arrest and ST elevation acute myocardial infarction undergoing primary PCI
Odds Ratio (95% CI) | p value | ||
---|---|---|---|
Gender (male) | 1.19 (0.47− 3.03) | 0.8 | |
Age >65 years | 0.4 (0.16− 1.16) | 0.09 | |
Cardiogenic shock | 3.17 (1.18− 8.48) | 0.02 | |
Multivessel disease | 3.0 (1.08− 8.3) | 0.03 | |
Renal failure | 4.2 (1.57− 11.21) | 0.004 | |
Anemia | 4.07 (1.28− 12.8) | 0.019 | |
Mechanical ventilation >48 h | 8.07 (2.6 – 25.08) | 0.0002 | |
Duration of stay in ICU >5 days | 9.96 (2.81 – 35.25) | 0.0002 | |
TIMI 3 flow post-PCI | 0.33 (0.12 – 0.92) | 0.03 |
Discussions
The results of the present study show that in patients with successfully resuscitated OHCA in the early phase of STEMI, following an urgent coronary revascularization procedure, the outcomes depend largely on the condition of the coronary circulation, the existing comorbidities and the time intervals from the onset of symptoms or of cardiac arrest to revascularization.
Cardiogenic shock has been shown to represent the most serious complication in STEMI patients [8]. In patients with myocardial infarction and cardiogenic shock, the use of vasopressor agents, age, cardiac arrest, renal failure and counterpulsation balloon insertion, have been proved to represent independent predictors of in-hospital mortality [8,9]. A study reporting on 572 consecutive patients with cardiogenic shock and AMI, indicated that a more severe clinical profile and serious arrhythmia are associated with a higher mortality [9].
In the present study, non-surviving patients exhibited a higher incidence of multi-vessel disease. It is important to note that a recent study reported significantly better outcomes in cases of multivessel revascularization as compared with revascularization of the culprit lesion alone in patients with cardiogenic shock [10]. Another study showed that in STEMI patients with cardiogenic shock and cardiac arrest, multi-vessel revascularization during primary PCI significantly improved the clinical outcome and survival rate [11]. Therefore, taking into consideration the significant correlation between the presence of multi-vessel disease and mortality in patients with OHCA, as shown in the present study, multi-vessel revascularization may be the treatment of choice instead of revascularization of the infarct related artery alone, in these complex cases.
However, in a study on 248 consecutive patients with acute myocardial infarction and cardiogenic shock, OHCA was not an independent predictor of death [12], while in another 5-year follow-up study on 3670 STEMI patients, cardiogenic shock at the initial stage was associated with a higher mortality risk at one year [13]. These studies prove that the high mortality associated with CS and cardiac arrest is mainly caused by the deterioration of the clinical status leading to CS and not by the cardiac arrest, which once resuscitated, is not associated with a significantly higher risk in the long term [14].
Similar to other studies, which indicated the involvement of LAD and LM in OAHC cases [14], the present study recorded a higher incidence of LAD and LM involvement in the non-survivor group. This suggests that culprit lesions located in the LAD or LM, are responsible for more severe myocardial infarctions, these arteries supplying a larger myocardial region. These lesions are more often associated with cardiogenic shock, and their urgent revascularization proves to be life-saving in many clinical conditions [15].
Other studies confirmed that anaemia on admission, and a TIMI 3 flow postPCI in the infarct-related artery, are critical determinants of in-hospital mortality. Similarly, in the present study, anaemia, renal failure, and a lower TIMI flow were powerful predictors of death in patients with OHCA, though the need for mechanical ventilation and a longer duration of stay in the ICU remained the most powerful predictors of death. In accord with other studies, patients who required mechanical ventilation presented a higher in-hospital mortality (44.3% vs. 1.5%, p<0.0001) [16]. Patients who spent a longer period in the ICU had a lower chance of survival compared to patients who were transferred to a coronary care unit within fort-eight hours. The duration of stay in the ICU was significantly higher in nonsurvivors, who spent a longer period intubated and developed specific complications such as sepsis. Once in the CCU, the duration of stay was relatively low, patients being transferred to the cardiology ward within two and a half days.
The time between the onset of symptoms and revascularization was shown to be directly correlated with mortality in STEMI population and corroborates the correlation between the respective time and mortality in OHCA patients, detailed in the current study. Different time intervals have been suggested as being associated with mortality in STEMI population, including the first contact with balloon time for PCI, first contact to needle time in case of thrombolysis, or ischemic time, i.e., from the onset of symptoms to the opening of the coronary artery.
According to authors’s knowledge, this is the first study to report a correlation between the arrest-to-balloon time, proving that a longer arrest-to-balloon time may be associated with a higher mortality. Therefore, STEMI networks should take steps to reduce this critical period by employing appropriate logistic measures.
Conclusions
The present study demonstrates that in patients surviving an OHCA in the early phase of a myocardial infarction, the presence of cardiogenic shock, renal failure, anaemia or multi-vessel disease, as well as a longer time from the onset of symptoms or of cardiac arrest to revascularization, are independent predictors of mortality. These data underline the need for a proper network organization in order to reduce the time intervals from the onset of cardiac arrest to revascularization. However, the most powerful predictor of death is the duration of stay in the ICU and the need for mechanical ventilation for more than 48 hours. Assessment of all these data could play a considerable role in risk stratification in OHCA patients with AMI, and may help to identify subsets of patients at increased risk for death following resuscitated cardiac arrest in the prehospital phase.
References
- 1.Madan M, Halvorsen S, Di Mario C. et al. Relationship between time to invasive assessment and clinical outcomes of patients undergoing an early invasive strategy after fibrinolysis for ST-segment elevation myocardial infarction: a patient-level analysis of the randomized early routine invasive clinical trials. JACC Cardiovasc Interv. 2015(8):166–74. doi: 10.1016/j.jcin.2014.09.005. [DOI] [PubMed] [Google Scholar]
- 2.The GUSTO Innestigators. An international randomized trial comparing four thrombolytic strategies for myocardial infarction. N Engl J Med. 1993(329):673–82. doi: 10.1056/NEJM199309023291001. [DOI] [PubMed] [Google Scholar]
- 3.Widimský P, Groch L, Zelízko M, Aschermann M, Bednár F, Suryapranata H.. Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory. The PRAGUE study. Eur Heart J. 2000(21):823–31. doi: 10.1053/euhj.1999.1993. [DOI] [PubMed] [Google Scholar]
- 4.Thiele H, Ohman EM, Desch S, Eitel I, de Waha S.. Management of cardiogenic shock. Eur Heart J. 2015(36):1223–30. doi: 10.1093/eurheartj/ehv051. [DOI] [PubMed] [Google Scholar]
- 5.Pedersen F, Butrymovich V, Kelbæk H. et al. Short- and longterm cause of death in patients treated with primary PCI for STEMI. J Am Coll Cardiol. 2014(64):2101–8. doi: 10.1016/j.jacc.2014.08.037. [DOI] [PubMed] [Google Scholar]
- 6.Kunadian V, Qiu W, Bawamia B, Veerasamy M, Jamieson S, Zaman A.. Gender comparisons in cardiogenic shock during ST elevation myocardial infarction treated by primary percutaneous coronary intervention. Am J Cardiol. 2013(112):636–41. doi: 10.1016/j.amjcard.2013.04.038. [DOI] [PubMed] [Google Scholar]
- 7.Romeo F, Acconcia MC, Sergi D. et al. The outcome of intraaortic balloon pump support in acute myocardial infarction complicated by cardiogenic shock according to the type of revascularization: a comprehensive meta-analysis. Am Heart J. 2013(165):679–92. doi: 10.1016/j.ahj.2013.02.020. [DOI] [PubMed] [Google Scholar]
- 8.Schwarz B, Abdel-Wahab M, Robinson DR, Richardt G.. Predictors of mortality in patients with cardiogenic shock treated with primary percutaneous coronary intervention and intra-aortic balloon counterpulsation. Med Klin Intensivmed Notfmed. 2015 Nov 23; doi: 10.1007/S00063-015-0118-8. [Epub ahead of print] [DOI] [PubMed] [Google Scholar]
- 9.Cao J, Liu W, Zhu J, Zhao H.. Risk factors and clinical characteristics of in-hospital death in acute myocardial infarction with IABP support. Int J Clin Exp Med. 2015(8):8032–41. [PMC free article] [PubMed] [Google Scholar]
- 10.Park JS, Cha KS, Lee DS. et al. Culprit or multivessel revascularisation in ST-elevation myocardial infarction with cardiogenic shock. Heart. 2015(101):1225–32. doi: 10.1136/heartjnl-2014-307220. [DOI] [PubMed] [Google Scholar]
- 11.Mylotte D, Morice MC, Eltchaninoff H. et al. Primary percutaneous coronary intervention in patients with acute myocardial infarction, resuscitated cardiac arrest, and cardiogenic shock: the role of primary multivessel revascularization. JACC Cardiovasc Interv. 2013(6):115–25. doi: 10.1016/j.jcin.2012.10.006. [DOI] [PubMed] [Google Scholar]
- 12.Ostenfeld S, Lindholm MG, Kjaergaard J. et al. Prognostic implication of out-of-hospital cardiac arrest in patients with cardiogenic shock and acute myocardial infarction. Resuscitation. 2015(87):57–62. doi: 10.1016/j.resuscitation.2014.11.010. [DOI] [PubMed] [Google Scholar]
- 13.Aissaoui N, Puymirat E, Simon T. et al. Long-term outcome in early survivors of cardiogenic shock at the acute stage of myocardial infarction: a landmark analysis from the French registry of Acute ST-elevation and non-ST-elevation Myocardial Infarction(FAST-MI) Registry. Crit Care. 2014;18 doi: 10.1186/s13054-014-0516-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Demirel F, Rasoul S, Elvan A. et al. Impact of out-of-hospital cardiac arrest due to ventricular fibrillation in patients with ST-elevation myocardial infarction admitted for primary percutaneous coronary intervention: Impact of ventricular fibrillation in STEMI patients. 1Eur Heart J Acute Cardiovasc Care. 2015(4):16–23. doi: 10.1177/2048872614547448. [DOI] [PubMed] [Google Scholar]
- 15.Ielasi A, Silvestro A, Personeni D. et al. Outcomes following primary percutaneous coronary intervention for unprotected left main-related ST-segment elevation myocardial infarction. J Cardiovasc Med (Hagerstown). 2015(16):163–9. doi: 10.2459/JCM.0000000000000075. [DOI] [PubMed] [Google Scholar]
- 16.Lazzeri C, Valente S, Chiostri M, Attana P, Mattesini A, Gensini GF.. Mechanical ventilation in the early phase of ST elevation myocardial infarction treated with mechanical revascularization. Cardiol J. 2013(20):612–7. doi: 10.5603/CJ.2013.0161. [DOI] [PubMed] [Google Scholar]
- 17.Qin Q, Qian J, Fan B, Ge L, Ge J.. Clinical Outcomes After Percutaneous Coronary Intervention in Acute Myocardial Infarction Due to Unprotected Left Main Coronary Artery Disease. J Invasive Cardiol. 2015;27:E153–7. [PubMed] [Google Scholar]
- 18.Shiraishi J, Kohno Y, Nakamura T. et al. Predictors of in-hospital outcomes after primary percutaneous coronary intervention for acute myocardial infarction in patients with a high Killip class. Intern Med. 2014(53):933–9. doi: 10.2169/internalmedicine.53.1144. [DOI] [PubMed] [Google Scholar]
- 19.Iqbal MB, Al-Hussaini A, Rosser G. et al. Predictors of survival and favorable functional outcomes after an out-of-hospital cardiac arrest in patients systematically brought to a dedicated heart attack center (from the Harefield Cardiac Arrest Study) Am J Cardiol. 2015;115:730–7. doi: 10.1016/j.amjcard.2014.12.033. [DOI] [PubMed] [Google Scholar]
- 20.Choudry FA, Weerackody RP, Timmis AD. et al. Importance of primary percutaneous coronary intervention for reducing mortality in ST-elevation myocardial infarction complicated by out of hospital cardiac arrest. Eur Heart J Acute Cardiovasc Care. 2015(4):378–85. doi: 10.1177/2048872614555990. [DOI] [PubMed] [Google Scholar]
- 21.Zimmermann S, Flachskampf FA, Schneider R. et al. Mild therapeutic hypothermia after out-of-hospital cardiac arrest complicating ST-elevation myocardial infarction: long-term results in clinical practice. Clin Cardiol. 2013(36):414–21. doi: 10.1002/clc.22131. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Søholm H, Wachtell K, Nielsen SL. et al. Tertiary centres have improved survival compared to other hospitals in the Copenhagen area after out-of-hospital cardiac arrest. Resuscitation. 2013(84):162–7. doi: 10.1016/j.resuscitation.2012.06.029. [DOI] [PubMed] [Google Scholar]
- 23.Möllmann H, Szardien S, Liebetrau C. et al. Clinical outcome of patients treated with an early invasive strategy after out-ofhospital cardiac arrest. J Int Med Res. 2011(39):2169–77. doi: 10.1177/147323001103900613. [DOI] [PubMed] [Google Scholar]